A multicentre study comparing two methods for serum free light chain analysis

Annals of Clinical Biochemistry

Volumn 50, Issue 3, 2013, Pages 255-261

  Lock, R J ^a   Saleem, R ^b   Roberts, E G ^a   Wallage, M J ^a   Pesce, T J ^c   Rowbottom, A ^b   Cooper, S J ^d   McEvoy, E D ^d   Taylor, J L ^d   Basu, S ^d  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b ROYAL PRESTON HOSPITAL   (United Kingdom)

^c NORTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^d NEW CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FUNCTION TEST KIT; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LIGHT CHAIN; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; MULTICENTER STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REPRODUCIBILITY;

EID: 84879427112     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563212473447     Document Type: Article

References (10)

1. Dispenzieri A, Kyle R, Merlini G, et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2009;23:215-24
2. Hoedemakers RM, Pruijt JF, Hol S, et al. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis. Clin Chem Lab Med 2011;50:489-95
3. Pretorius CJ, Klingberg S, Tate J, Wilgen U, Ungerer JP. Evaluation of the N Latex FLC free light chain assay on the Siemens BN analyser: precision, agreement, linearity and variation between reagent lots. Ann Clin Biochem 2012;49:450-5
4. UK NEQAS. Immunology, Immunochemistry and Allergy Annual Report 2010. See http://www.kpmd.co.uk/immqas/downloads/ Annual_Report_2010_V1.1_FINAL.pdf (last checked 26 July 2012)
5. CLSI. Method comparison and bias estimation using patient samples; Approved guideline - second edition (interim revision). CLSI document EP09-A2-IR. Wayne, PA, USA: Clinical Laboratory Standards Institute, 2010
6. Katzmann JA, Clark RJ, Abraham RS, et al. Serum reference intervals and diagnostic ranges for free k and free l immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 2002;48:1437-44
7. Lock RJ, Unsworth DJ. Immunoglobulins and Immunoglobulin subclasses in the elderly. Ann Clin Biochem 2003;40:143-8
8. Robson EJD, Taylor J, Beardsmore C, Basu S, Mead G, Lovatt T. Utility of serum free light chain analysis when screening for lymphoproliferative disorders. Lab Med 2009;40:325-9
9. Palladini GDA, Gertz MA, Kumar S, et al. Validation of the criteria of response to treatment in AL amyloidosis. Blood 2010;11:1364a
10. Leung N, Gertz MA, Zeldenrust SR, et al. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Kidney Int 2008;73:1282-8